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Abstract
Background: Chronic inflammation and intestinal metaplasia lead to gastric and esophageal adenocarcinoma. Past research has
provided controversial findings about the etiology of inflammation and intestinal metaplasia in the cardia and the Z-line.
Objectives: The aim of this study was to evaluate clinicopathological findings of the cardia and gastroesophageal junction in adult
candidates for endoscopy in Qazvin, Iran.
Methods: Biopsy was performed for 124 ambulatory adult patients without any evidence of cancer. Specimens were obtained from
the antrum and the cardia of the stomach, the Z-line, and 2 cm above the Z-line. A comparison was made between the histological,
clinical and endoscopic data obtained from the patients.
Results: Helicobacter pylori were significantly related to active inflammation in the antrum and the cardia, but not in the Z-line.
Another finding was that active carditis was related to active antritis and active Z-line inflammation. A further observation was the
positive correlation between cardiac and Z-line metaplasia. Finally, a relationship was observed between the type of cardiac mucosa
and the presence of metaplasia in the cardia and the Z-line.
Conclusions: The study revealed that inflammation in the cardia and, to a lesser extent, the Z-line is related toH.pyloriand antral gas-
tritis and that the metaplasia of these areas is related to gastroesophageal reflux disease. Lastly, both H. pylori and gastroesophageal
reflux disease are important in the pathology of these areas.
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1. Background
Gastric and esophageal cancers are two of the most
common human cancers. The most common type of gas-
tric cancer is gastric adenocarcinoma and mostly follows
chronic atrophic gastritis and intestinal metaplasia (IM),
conditions which are most commonly caused byHelicobac-
ter pylori (H. pylori) (1).
Esophageal adenocarcinoma, which has been shown
to have increased in the recent years (2), is more commonly
seen in the distal part of the esophagus adjacent to the gas-
tric mucosa (1, 2) and follows chronic esophagitis and a
form of esophageal IM called Barrett’s Esophagus (BE) (1, 3,
4). The most common cause of BE is the Gastroesophageal
Reflux Disease (GERD) (1). Gastroesophageal Reflux Disease
itself is a common illness (5), which causes many problems
and decreases quality of life (6).
A subcategory of adenocarcinoma is the adenocarci-
noma of the gastroesophageal junction or the Z-line (1). Al-
though gastric and esophageal adenocarcinomas look his-
tologically similar, they have different clinical courses and
prognoses (1, 7).
The treatment of H. pylori gastritis has been associated
with a reduction in the case of gastric adenocarcinoma, yet
no such reduction has been observed in the case of adeno-
carcinoma affecting the cardia, which is an area distal to
the Z-line with an unclear origin and histology (8, 9); there
has even been reports of an increase in the number of such
cases of adenocarcinoma (1, 9, 10). Aside from that, it seems
that H. pylori is protective of Z-line mucosa (1, 11).
Considering the inconclusive data from previous re-
search about the etiology and pathogenesis of Z-line
and cardiac adenocarcinoma, it is necessary to further
study factors that contribute to cancer. Previous studies
have shown that esophageal and gastric cancers are two
common cancers in Iran (2, 12). Helicobacter pylori and
GERD have been reported as predisposing factors of the
esophageal and gastric cancers (12); but risk factors may
vary by race and ethnicity in different populations. In addi-
tion, no previous study has been performed on this subject
in Qazvin.
2. Objectives
The aim of this study was to evaluate clinicopatholog-
ical findings of the cardia and gastroesophageal junction
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in adult candidates for endoscopy in Qazvin, Iran.
3. Methods
This cross sectional study was conducted on adult pa-
tients referred to the endoscopy ward of Booali Sina Hos-
pital from October 2011 to October 2014. The study was
confirmed by the medical ethics committee of Qazvin Uni-
versity of Medical Sciences. Written consent form was ob-
tained from all patients.
Inclusion criteria were being an adult patient, and lack
of any evidence of cancer or a critical condition such as
varicose esophagus or history of gastrointestinal (GI) tract
surgery. All eligible patients in the study period were en-
tered using the census method. The exclusion criteria
were systemic or skin disorders involving the GI tract, his-
tory of chemotherapy, radiotherapy, and ingestion of cor-
rosive materials. In addition, patients who had received
treatment for H. pylori not long before the experiment
or those who had taken non-steroidal anti-inflammatory
drugs (NSAIDs), antibiotics, steroid and anti-reflux drugs,
and proton-pump inhibitors during the two weeks prior to
the experiment were excluded from the study.
The demographic data were age, gender, body mass in-
dex (BMI), smoking habit, and coffee and alcohol consump-
tion. Endoscopy was performed by a single gastroenterol-
ogist, using Olympus 260, Japan.
The patients were assigned to three groups depend-
ing on their complaints: (1) the GERD group, where the
patients had the classic symptoms of the disease, includ-
ing a heartburn sensation at least twice per week during
the four weeks prior to the experiment; (2) the dyspepsia
group, where the patients had other GI symptoms such
as bloating, epigastric pain, early fullness during meals,
nausea and vomiting; and (3) the “mixed or other” group,
where the patients had non-classic symptoms of GERD or
other indications for endoscopy.
The Los Angeles classification was used as follows for
describing the esophagitis (13): the Z-line was defined as
an area between the pale pink esophageal mucosa and the
dark red gastric mucosa, hiatus hernia was defined as a sit-
uation in which proximal gastric folds were at least 2 cm
away from diaphragmatic hiatus (14), and BE was defined
as a situation in which there was salmon-colored mucosa
in the tubular esophagus (1).
Any unusual findings in the endoscopy of the upper
GI tract were reported, and biopsy was performed as fol-
lows: one specimen or two from the antrum, two speci-
mens from the cardia in the retroflexion view, four speci-
mens from the Z-line, two specimens from 2 cm above the
Z-line, at least one specimen from any portions suspicious
for BE, and one specimen from any abnormal or suspicious
region.
The specimens were fixed using 10% formalin and were
sent for blind histopathology examination. They were ex-
amined for H. pylori (using Hematoxylin and Eosin and
Giemsa staining) and goblet cells (to determine IM). More
specifically, BE was considered if goblet cells were seen in
the specimens taken from the endoscopically suspicious
regions of esophagus mucosa (1).
The specimens obtained from the cardia were exam-
ined for the type of the columnar mucosa: (a) mucous or
mucous/oxyntic and (b) oxyntic (1).
The specimens from 2 cm above the Z-line were graded
for esophagitis, including no inflammation, mild reactive
esophagitis, mild active esophagitis, and active esophagi-
tis (13).
The Sydney grading system was used for grading gastri-
tis. This system specifies the following degrees of inflam-
mation: 0 (none), 1 (mild), 2 (moderate) and 3 (severe).
Data analysis was performed using SPSS 18 (2010). Mean
and standard deviation were used to describe frequency
data. Chi-square test, t-test, and Spearman rank-order cor-
relation coefficient were also used. P values of less than
0.05 were considered as statistically significant.
4. Results
The patients included 99 females (79.8%) and 25 males
(20.2%) and ranged in age from 20 to 80, with the average
age being 42.8 (SD = 15.04). No alcohol drinking or regular
coffee consumption was detected, and only one male pa-
tient was a smoker.
Table 1 shows the relationship between the existence or
lack of H. pylori and the three categories of clinical com-
plaints of the patients. As can be seen, there was no re-
lationship between H. pylori and clinical complaint (P =
0.069); however, the ratio of H. pylori negative to H. pylori
positive was more significant in the GERD group (5:1) than
in the other two groups.
Table 1 also demonstrates the relationship between H.
pylori and histological findings. More specifically, H. py-
lori was more strongly associated with antral or cardiac
chronic inflammation (P < 0.001) than with Z-line chronic
inflammation (P = 0.028). Moreover, no relationship was
observed between H. pylori and esophagitis (P = 0.801).
It can also be seen in Table 1 that H. pylori had a sta-
tistically significant relationship with active inflammation
both in the antrum and the cardia (P < 0.05), but not in the
Z-line.
In addition, H. pylori was not related to IM in any of the
sites under study (i.e., antrum, cardia, and Z-line, with P val-
ues of 0.455, 0.466, and 0.711, respectively). It is worth not-
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Table 1. A Comparison of Clinical and Histological Findings Considering Helicobacter pylori Infection State of the Patientsa
Clinical and
Histological Factors
H. P (-)b H. P (+)c Total P Value
Clinical Complaints
GERD 10 (83.3) 2 (16.7) 12 (9.7)
0.069Dyspepsia 70 (74.5) 24 (25.5) 94 (75.8)








None 14 (100.0) 0 14 (11.3)
< 0.001
Mild 63 (87.5) 9 (12.5) 72 (58.1)
Moderate 11 (30.6) 25 (69.4) 36 (29.0)
Severe 1 (50.0) 1 (50.0) 2 (1.6)
Cardia
None 17 (100.0) 0 17 (13.7)
< 0.001
Mild 59 (79.7) 15 (20.3) 74 (59.7)
Moderate 13 (40.6) 19 (59.4) 32 (25.8)
Severe 0 1 (100.0) 1 (0.8)
Z-line
None 9 (100.0) 0 9 (7.3)
0.028
Mild 53 (75.7) 17 (24.3) 70 (56.4)
Moderate 27 (60.0) 18 (40.0) 45 (36.3)





Yes 5 (33.3) 10 (66.7) 15 (12.1)
< 0.001
No 84 (77.1) 25 (22.9) 109 (87.9)
Cardia
Yes 6 (46.2) 7 (53.8) 13 (10.5)
0.047
No 83 (74.8) 28 (25.2) 111 (89.5)
Z-line
Yes 4 (44.4) 5 (55.6) 9 (7.3)
0.116
No 85 (73.9) 30 (26.1) 115 (92.7)
aValues are expressed as No. (%).
bCases where H. pylori does not exist.
cCases where H. pylori exists.
ing that at this point we observed no relationship between
GERD and severity of inflammation or IM in the cardia or
the Z-line.
The relationship of degrees of esophagitis to clinical
complaints, age, gender, BMI, and hiatus hernia is reported
in Table 2. As is clear from the data, esophagitis only corre-
lated with age (P = 0.013) and BMI (P = 0.038). Another ob-
servation was that BMI was inversely related to histological
esophagitis.
It is worth noting at this point that the relationship of
BE with the variables mentioned in the previous paragraph
was among our concerns. However, since only five patients
(4.03%) were diagnosed with BE, we decided not to report
the details. Barrett’s Esophagus was only found to corre-
late with clinical complaint (P = 0.001) and that it was more
prevalent in GERD patients.
Table 3 presents the data obtained for the correlations
among inflammations (both chronic and active) in the
antrum, cardia, and Z-line. It can be seen that chronic
inflammations in all the three sites were correlated with
one another. In addition, active carditis was found to cor-
relate with active antritis and active Z-line inflammation;
however, no correlation was observed between active antri-
tis and active Z-line inflammation. Furthermore, as for
the correlation among chronic and active inflammations
across the three sites under discussion, the following ob-
servations were made: chronic antritis correlated with ac-
tive inflammation in the antrum and the cardia, but not
in the Z-line; chronic carditis correlated with active inflam-
mation in the cardia and the antrum, but not in the Z-line;
and chronic Z-line inflammation was correlated with ac-
tive inflammation in the Z-line and the antrum, but not in
the cardia.
Table 4 summarizes the data for the correlations
among antral, cardiac, and Z-line IM and BE. It is clear that
there was a significant positive relationship between car-
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Age, y 41.4 41.5 56.4 60.5 42.8 0.013
Gender
Female 73 (73.7) 17 (17.2) 5 (5.1) 4 (4.0) 99 (79.8)
0.472
Male 16 (64.0) 7 (28.0) 2 (8.0) 0 25 (20.2)
BMI
< 25 33 (63.5) 12 (23.1) 5 (9.6) 2 (3.8) 52 (41.9)
0.03825 - 30 31 (67.4) 12 (26.1) 1 (2.2) 2 (4.3) 46 (37.1)
> 30 25 (96.2) 0 1 (3.8) 0 26 (21.0)
Clinical
complaints
GERD 8 (66.7) 3 (25.0) 0 1 (8.3) 12 (9.7)
0.425Dyspepsia 68 (72.3) 18 (19.2) 6 (6.4) 2 (2.1) 94 (75.8)
Mixed or other 13 (72.2) 3 (16.6) 1 (5.6) 1 (5.6) 18 (14.5)
Hiatus hernia
Negative 65 (72.2) 15 (16.7) 7 (7.8) 3 (3.3) 90 (72.6)
0.389
Positive 24 (70.6) 9 (26.5) 0 1 (2.9) 34 (27.4)
aValues are expressed as mean or No. (%).
Table 3. Correlations Among Antral, Cardiac, and Z-Line Inflammations










Chronic antritis - 0.324a 0.499a 0.230b 0.271b 0.011
Active antritis - - 0.329a 0.438a 0.195c 0.087
Cardia
Chronic carditis - - - 0.269b 0.229c 0.034




- - - - - 0.181c
Active
inflammation




diac and Z-line IM (P = 0.004, r = 0.260), but there was no
relationship between the other anatomic sites.
Table 5 shows how type of cardiac mucosa is related
to cardiac and Z-line IM. The data indicate that the type of
cardiac mucosa was correlated with both cases of IM, with
cardiac IM having a stronger correlation (P = 0.001). More
specifically, if the cardiac mucosa is of the mucous or mu-
cus/oxyntic type, there is greater likelihood that the site
under discussion will be aﬄicted with IM.
5. Discussion
A major finding of the study was that H. pylori did
not bear a significant relationship with clinical complaint.
However, the ratio of H. pylori negative to H. pylori posi-
tive was more significant in GERD patients. This latter find-
ing supports the theory that H. pylori is protective against
GERD (4, 15).
We also found a strong relationship between H. pylori
and the severity of inflammation in the antrum and the
cardia, and also betweenH.pyloriand the presence of active
inflammation in these sites despite the small number of
cases and the low percentage of H.pyloripositivity. The rela-
tionship between H. pylori and the cardia has also been re-
ported elsewhere (4, 15-17), even when most patients were
negative for H. pylori (18). The Z-line showed a different
pattern: A less strong relationship between H. pylori and
the severity of Z-line inflammation and no relationship be-
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Table 4. The Correlations Among Antral, Cardiac, and Z-Line Intestinal Metaplasia
Anatomic Site Intestinal Metaplasia
Antrum Cardia Z-Line Esophagus (BE)
Intestinal metaplasia
Antrum - 0.71 -0.63 0.145
Cardia - - 0.260a 0.09
Z-line - - - 0.101
Esophagus (BE) - - - -
Abbreviation: Barrett’s esophagus.
aP < 0.01.
Table 5. The Relationship Between Type of Cardiac Mucosa With Intestinal Metaplasia (IM) in the Cardia and Z-Linea
Types of Mucosa in the Cardia P Value
Intestinal Metaplasia Mucous or Mucous/Oxyntic Oxyntic Total
Anatomic site
Cardia
No 21 (18.4) 93 (81.6) 114 (91.9)
0.001
Yes 7 (70.0) 3 (30.0) 10 (8.1)
Z-line
No 23 (20.0) 92 (80.0) 115 (92.7)
0.027
Yes 5 (55.6) 4 (44.4) 9 (7.3)
aValues are expressed as No. (%).
tween H. pylori and the presence of active Z-line inflamma-
tion.
Another point that deserves to be mentioned is that the
relationship of H. pylori to cardiac and Z-line inflammation
becomes less strong as we move from the distal to the prox-
imal part of the stomach. Furthermore, when it comes to
inflammation in the Z-line, some other factors may be im-
portant as well.
Furthermore, no relationship was seen between H. py-
lorion the one hand and antral, cardiac and Z-line IM on the
other. Three reasons can be given to explain this finding:
(1) we had a limited number of IM cases in our study, (2)
H. pylori was loosely attached to the metaplastic mucosa,
and considering thatH.pylori tends to disappear in the case
of chronic mucosal inflammation (1), (3) rather than ex-
cluding the patients, who had undergone treatment for H.
pylori many years prior to the research, we only excluded
those, who had been treated for H. pylori shortly before the
research. Moreover, it has been shown that gastric mucosa
may not return to normal despite H. pylori eradication (19).
A number of studies have not found a significant re-
lationship between H. pylori and cardiac IM, but have re-
ported a relationship between H. pylori and carditis (16). In
contrast, some studies found that cardiac IM is related to
H. pylori and antral IM (3).
Much research has focused on the relationship be-
tween cardiac IM and a few other factors. For instance,
while cardiac IM has been found to be positively related to
age (16), it has been shown to be negatively related to BMI
(16), GERD, endoscopic esophagitis, and hiatus hernia (3).
Moreover, in our study, GERD had no correlation with
cardiac or Z-line inflammation and IM, and perhaps this
was because our study had the limitation of a small num-
ber of GERD cases.
Age was the only risk factor, which was histologically
related to the degrees of esophagitis in our study. We also
found a negative relationship between BMI and histologi-
cal esophagitis, yet this finding may be accidental because
most of our patients had a low BMI. We did not observe a re-
lationship between esophagitis and hiatus hernia, which
may be due to the limited number of GERD or esophagitis
cases in our study. It should be noted that while some stud-
ies reported a relationship with hiatus hernia (14) and BMI
(1), some other studies did not find such a relationship (12,
16). Other risk factors (i.e. alcohol and smoking) were non-
existent or minimal in our patients.
We were also interested in the relationship of BE with
clinical complaints, age, gender, BMI, and hiatus hernia.
Only 4.03% of the patients in our study were diagnosed
with BE. The percentages reported in other studies for the
prevalence of BE ranged between 1% (3) and 13% (16). Fur-
thermore, a prevalence of 5.4% was reported for Iranian pa-
tients with dyspeptic problems (20). The prevalence of BE
depends on issues such as the prevalence of etiological fac-
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tors in the population under study, the type of clinical com-
plaint, and indications for endoscopy. One study recom-
mended to take biopsy specimens from the Z-line to rule
out BE even though no endoscopic evidence of BE could be
found (21).
We observed a correlation between BE and clinical
complaints. Some other studies have also reported a corre-
lation between BE and GERD symptoms (3, 16, 20). This has
clinical implications, meaning that it is necessary to pay
greater attention to BE in patients with GERD complaints.
The present research found no relationship between
age and BE although BE patients were on average older
than the other patients. In addition, although four out of
five BE patients in our study were female, no relationship
was seen between gender and BE, possibly because of the
significantly larger number of female patients. As for fe-
male predominance in our study, it should be noted that
patients could participate in our study regardless of gen-
der if inclusion and exclusion criteria were satisfied and
also if patients agreed to participate. Although gastric and
esophageal cancer and perhaps the predisposing factors
pertinent to them are more common among males (2), this
cannot predict similar predominance in people, who refer
to medical centers. A study from Iran reported female pre-
dominance (2 to 1) in patients with GERD symptoms (5).
It is worth noting that despite the predominance of BE
(1, 16) and esophageal adenocarcinoma (2) among males,
no relationship has been reported in the literature be-
tween BE and gender (3). Finally, unlike studies that have
reported a relationship between BE and BMI, and hiatus
hernia (3), we found no such relationship; an observation
which may be attributed to the small number of our BE
cases.
Another key observation of the study was the signif-
icant correlation between chronic inflammations in the
antrum, cardia and Z-line. More specifically, while the
correlation between chronic antritis and chronic carditis
was the strongest, the relationship between chronic antri-
tis and the chronic inflammation in the Z-line was the
least strong. In addition, a relationship was found be-
tween active carditis and active antritis and also between
active carditis and active Z-line inflammation, but no such
correlation was observed between active antritis and ac-
tive Z-line inflammation. Moreover, as for the correlations
among chronic and active inflammations across the three
sites at issue, chronic antritis was correlated with active
antritis and active carditis. Similarly, chronic carditis cor-
related with active carditis and active antritis. Likewise,
chronic inflammation in the Z-line was related to active in-
flammation in this area and also in the antrum.
We only found a relationship between cardiac and Z-
line IM, but not between cardiac and antral IM or between
Z-line and antral IM. It should also be noted that Z-line IM
was observed in nine (equaling 7.3%) of our patients. In a
study similar to ours, this figure was 15% (3). On the other
hand, while we observed 10 cases of cardiac IM (8.1%), an-
other study reported a much higher percentage (42%) (16).
Another significant outcome of the study was the cor-
relation between the type of mucosa in the cardia and
the presence of cardiac and Z-line IM. Since the specimens
taken from these two sites were only a few millimeters
away from each other, such a relationship seems logical.
We also found that if the cardiac mucosa is of the mu-
cous or mucus/oxyntic type, the site under discussion is
more likely to be affected by IM. This observation implies
the effect of the squamo-oxyntic gap on IM. This gap is a
columnar epithelium between the squamous mucosa of
the esophagus and the oxyntic mucosa of the stomach and
it may be lined by mucous or mucous/oxyntic epithelium
(22). In our study, cardiac and Z-line IM was more common
in patients, who had this gap (i.e., the patients with a mu-
cous or mucous/oxyntic type of mucosa in cardiac speci-
mens). As this gap is equal to the microscopic sign of GERD
(21, 22), we can suggest that microscopic GERD is related to
cardiac and Z-line IM.
Overall, it can be concluded that both H. pylori and
GERD probably have roles to play in the development of
adenocarcinoma in the cardia and the Z-line, despite the
fact that, as mentioned previously, some studies suggest
thatH. pylori is protective against GERD-induced injury (11).
The reason may be a decrease in gastric acid secretions
as inflammation and atrophy of the gastric corpus is sec-
ondary to H. pylori infection (1). Now, the question is why
H. pylori and GERD cause inflammation in the cardia and
the Z-line if atrophy has not happened yet. A study into
the relationship of gastric pathology (including inflam-
mation, H. pylori infection, and IM) to high-grade dyspla-
sia and/or adenocarcinoma of the distal esophagus found
that changes made by H. pylori infection to the composi-
tion of gastric acid in the patients with gastric pathology
(despite a low prevalence of 17.8%) were statistically more
significant than the control group (P = 0.01), suggesting
that these changes may have a role in developing dysplasia
and neoplasia (23). Given this, it could be suggested that
H. pylori may reduce or intensify the adverse effect of GERD
depending on the stage of gastritis. This hypothesis could
be clarified by future studies.
This study had some limitations including its cross sec-
tional design and the low number of participants. In ad-
dition, patients with dyspepsia were more frequent than
patients with GERD. Conducting longitudinal studies with
higher sample sizes will help better understanding of clin-
icopathological findings of these regions.
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5.1. Conclusions
This study showed that the cardia and, to a lesser de-
gree, the Z-line were affected by H. pylori and antral gastri-
tis. Moreover, the relationship between microscopic GERD
and the presence of IM both in the cardia and the Z-line
supports the role of GERD in inducing inflammation and
pathological changes in the two areas.
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